Cancer-Bio-Health Competitiveness Cluster

Training - Research - Industry: pillars of the cluster

Based on training - research - industry, CBS connects players in innovation health academic laboratories, start-ups, SMEs, industrial groups, support structures and R & D funding ....Objectives   : Stimulate and accelerate the creation of projects, products, innovation and value. The Pole stimulates both therapeutic innovations for the benefit of the patient, creating wealth and jobs.

Its main tasks are to:

• Animate the local bio-health sector: encourage meetings and synergies between different actors, encourage multidisciplinary projects, lead innovation
• Get involved in local economic development Midi-Pyrénées and Limousin regions:

-  Certify collaborative R & D and structuring projects,
- Support the establishment of technology platforms,
- Accompany local TPE and SMEs, especially to international markets,
- Conduct an active international policy through partnerships with clusters of reference
- Enable local "inter-cluster" (with Aerospace Valley for topics related to home health, monitoring and patient autonomy  [http://www.aerospace-valley.com/en], - Agrimip Innovation

- Cancers by food [http://www.agrisudouest.com/en/] et nationales.

CBS center and Oncopole

Funding

Cancer-Bio-Santé Cluster is funded by the State, Regional Councils of Midi-Pyrénées and Limousin, the General Council of Tarn, Toulouse Métropole Urban Community, Sicoval the Community of Agglomeration of Castres-Mazamet.The division also has private funding through membership fees and support from several banks.

Priority actions for 2017

• Promoting Oncopole internationally.
• The installation of new businesses attracted by the prospects of synergy that the campus offers (on the subject of clinical trials in particular).
• The transformation of "project factory" into a real "growth plant", with effects already measured in terms of number of patents, products, jobs and active companies in the sector.

http://www.cancerbiosante.fr/fr/
 

 

bruno_legrand.jpg

«At a time when it is becoming increasingly difficult for pharmaceutical industry to lead a single molecule towards the market and the bedside, partnerships are the only option in a tensioned competitive and regulatory environment to feed the pipelines of innovations and new therapies: the role of a center as CBS is now major and crucial»

Bruno Le Grand, Head of the Predevelopment Opportunity Office at Pierre Fabre and a member of the of Cancer-Bio-Santé Competitiveness Cluster bureau.